Kidney Damage In Patients With Severe Fall In eGFR

• Status: Terminated
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a pilot study using a randomized, double blinded, comparison of two iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled must have and estimated glomerular filtration [eGFR] < 30 mL/min/1.73 m2. Statistical summaries will be presented to analyse the various laboratory tests for the two groups.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bracco Diagnostics, Inc

Criteria

Inclusion Criteria:

• Provides written Informed Consent

• Is at least 18 years of age;

• Is scheduled for or likely to undergo percutaneous coronary intervention;

• Has documented estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m2 calculated with the MDRD formula within 72 hours prior the enrolment.

Exclusion Criteria:

• Is a pregnant or lactating female

• Has a history of severe congestive heart failure

• Has a history of hyperthyroidism

• Has unstable renal function

• Has a history of hypersensitivity to iodinated contrast agents